Why global neurology? In a presentation featured by the Johns Hopkins Alumni Association, Dr. Deanna Saylor addresses the answer to this question and shares her experiences developing neurologic research, care and training in Zambia.
Imagine going to the doctor to be tested for HIV in sub-Saharan Africa. You will likely have to travel a long distance to get to a clinic, and, once you arrive, your blood will be drawn and sent to a central testing laboratory for analysis. You will then have to wait for the results to […]
In November 2015, the FDA approved the HIV-1 medication Genvoya, a once-daily pill containing fixed doses of the HIV drugs elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide. This is the latest once-daily medication to be produced to treat HIV, a disease that used to be managed primarily with many different pills taken multiple times a day. […]
A potential tool to combat the HIV epidemic in Baltimore is gaining attention, and it may involve an unlikely location — the church. Researchers at the Johns Hopkins Bloomberg School of Public Health and the University of Memphis School of Public Health have identified church attendance as a possible way to encourage communication about sexual […]